PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Compliance Implementation Services

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

CIS Takes Government Calculations Service to Next Level with New Director - Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Matt Gorman has joined the management team as Director of Government Pricing Programs
CIS Takes Government Calculations Service to Next Level with New Director

 

NewswireToday - /newswire/ - Philadelphia, PA, United States, 2010/04/05 - Compliance Implementation Services (CIS), a pharmaceutical compliance consulting firm, announced today that Matt Gorman has joined the management team as Director of Government Pricing Programs.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Matt Gorman has a diverse array of industry experience that ranges from systems integration to regulatory compliance audits and software training instruction. Additional professional activities involve strategic decision analyses, which resulted in a more holistic viewpoint when tackling compliance projects.

As Director of Government Pricing Programs, Matt will lead growth and development of the CalcPartner™ and ClaimsPartner™ business unit. These proprietary services offer clients both data storage and program-driven services for effectively conducting and preserving all government pricing calculations and processing quarterly Medicaid claims.

“The addition of Matt Gorman as Director of the CalcPartner service offering enables CIS to take this area to the next level,” said Chris Cobourn, VP Regulatory Compliance and Practice Lead. “He is able to work directly with CIS executive leadership to ensure that all CalcPartner and ClaimsPartner activities are aligned with CIS’ corporate mission and vision.”

Matt Gorman comes to CIS with over eleven years of experience at a “Big 4” accounting firm with emphasis on project management, information technology, financial analysis, risk assessment and management, and business process education for the pharmaceutical, chemical and manufacturing industries. He has specialization in the pharmaceutical industry, including government pricing and PBM rebate adjudication. Matt also has consulting experience related to product portfolio management, utilizing the discipline of Multiple Objective Decision Analysis. Matt received both his Executive MBA and Bachelor of Chemical Engineering from Villanova University.

About CIS
Compliance Implementation Services (cis-partners.com) is a consulting firm specializing in compliance strategies for pharmaceutical companies, from Global Clinical Research and Development through U.S. Commercial Compliance and Government Programs. Founded in 2004, the firm’s deep understanding of industry laws and regulations, innovative and practical applications, and custom solutions help its clients establish a “Culture of Compliance” that is both meaningful and practical.
CIS experts quickly identify exposure to compliance risks, help develop a strategic plan, and ensure its implementation and ongoing adherence to legal and regulatory requirements.

CalcPartner™ and ClaimsPartner™ are trademarks of Compliance Implementation Services, LLC.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Compliance Implementation Services

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


CIS Takes Government Calculations Service to Next Level with New Director

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Marni Schribman - CIS-Partners.com 
919-463-1990 marnischribman[.]cis-partners.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Compliance Implementation Services securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Compliance Implementation Services / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine
Somatuline® Autogel® 120 Mg Receives Japanese Approval for A New Indication for the Treatment of Gastro-entero-pancreatic Neuroendocrine Tumors
OTC Topical Drugs Market Size will Grow Profitably in the Near Future 2017-2025 Finds PMR
Bioinformatics Market Size to Expand at 20.4% CAGR through 2020 Reports Persistence Market Research
Australia Nitric Acid Market Expected to Reach at Value of $1.3B by 2024 End Says PMR
Commodity Chemicals Market Projected to be Resilient by 2020 Says Persistence Market Research
Cell Expansion Market Set to Garner Staggering Revenues by 2025 Reports PMR
Soft Tissue Sarcoma Treatment Market Revenue Predicted To Go Up by 2025 Finds Persistence Market Research
Persistence Market Research Publishes Biopharmaceutical Membrane Filtration Market Forecast Over 2017-2025
Global Tablet Processing & Packaging Equipment Market to Reach USD 5,268.8 Million by 2022

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  JobsWare.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)